Daniela Kuellenberg de Gaudry Selected Research

beta-casomorphins

2/2022

A1- and A2 beta-casein on health-related outcomes: a scoping review of animal studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Kuellenberg de Gaudry Research Topics

Disease

2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
1	Noncommunicable Diseases 02/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Myocardial Infarction 01/2022
1	Diabetes Mellitus 01/2020
1	Body Weight (Weight, Body) 01/2020

Drug/Important Bio-Agent (IBA)

1	Caseins (Casein)FDA Link 02/2022
1	Opioid Peptides (Opioid Peptide)IBA 02/2022
1	beta-casomorphinsIBA 02/2022
1	Glutens (Glutelin)IBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	Nutritive SweetenersIBA 01/2020
1	Non-Nutritive SweetenersIBA 01/2020
1	Sweetening Agents (Sweeteners)IBA 01/2020
1	CarbohydratesIBA 01/2020
1	SugarsIBA 01/2020

Therapy/Procedure

1	Gluten-Free Diet 01/2022